Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine

Detalles Bibliográficos
Autores principales: Miltiades, P, Lamprianidou, E, Vassilakopoulos, T P, Papageorgiou, S G, Galanopoulos, A G, Vakalopoulou, S, Garypidou, V, Papaioannou, M, Hadjiharissi, E, Pappa, V, Papadaki, H A, Spanoudakis, E, Tsatalas, K, Kotsianidis, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944665/
https://www.ncbi.nlm.nih.gov/pubmed/24583533
http://dx.doi.org/10.1038/bcj.2014.9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944665/
https://www.ncbi.nlm.nih.gov/pubmed/24583533
http://dx.doi.org/10.1038/bcj.2014.9

Ejemplares similares